About
Psychedelics
Areas of Focus
Categories
PsychedelicBiotech
Clinical Trials (32)
View allTotal Trials
32
As Lead Sponsor
29
As Collaborator
3
Total Enrollment
989
By Phase
PHASE1: 5PHASE2: 16PHASE3: 5PHASE1/PHASE2: 1
By Status
COMPLETED: 20WITHDRAWN: 4TERMINATED: 3RECRUITING: 2NOT_YET_RECRUITING: 1ACTIVE_NOT_RECRUITING: 1NO_LONGER_AVAILABLE: 1
Clinical Trials Pipeline31 trials
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2003
2004
2005
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
2027
2028
2029
Today
Hover over trial bars to see details
Recent Trials
NCT03606538Lead Sponsor
MDMA in Subjects With Moderate Hepatic Impairment and Subjects With Normal Hepatic Function
PHASE1Not yet recruiting
16 participants
Started: Mar 29, 2026 · Completed: Dec 31, 2028
NCT04454684Lead Sponsor
A Multi-Site Study of MDMA-Assisted Psychotherapy for Eating Disorders
PHASE2Withdrawn
Started: Feb 28, 2026 · Completed: Aug 10, 2028
NCT04073433Lead Sponsor
Psychological Effects of Methylenedioxymethamphetamine (MDMA) When Administered to Healthy Volunteers (MT-2)
PHASE1Withdrawn
Started: Dec 31, 2024 · Completed: Dec 31, 2025
NCT06117306Collaborator
MDMA-assisted Massed Prolonged Exposure for PTSD
PHASE3Recruiting
20 participants
Started: Oct 25, 2024 · Completed: Jan 1, 2026
NCT05979844Collaborator
MDMA-assisted Brief Cognitive Behavioral Conjoint Therapy for PTSD
PHASE3Active, not recruiting
16 participants
Started: Oct 6, 2023 · Completed: Sep 30, 2025
Locations (1)
Headquarters
San Jose, CA, United States
Map
Loading map...